Correction: Evaluation of bleeding events in patients receiving acalabrutinib therapy.
Kumar PS, Wiczer T, Rosen L, Pollauf AJ, Zheng A, Palettas M, Azali L, Bhat SA, Byrd JC, Grever MR, Rogers KA, Woyach JA, Kittai AS.
Kumar PS, et al. Among authors: woyach ja.
Leukemia. 2023 Jul;37(7):1588. doi: 10.1038/s41375-023-01927-8.
Leukemia. 2023.
PMID: 37231141
No abstract available.